Probiotics company BioBrew Ltd will be trialling one of its flagship products during lamb weaning to see whether it reduces the need for anthelmintics (antiparasitic drugs).
BioBrew has received $24,000 through the Ministry for Primary Industries' (MPI) Sustainable Food and Fibre Futures programme to investigate the effectiveness of using CalfBrew in treating lambs with digestive disorders.
This will be incorporated with low doses of anthelmintic for stimulating natural immunity to gastrointestinal parasites.
Results will be measured through industry standards such as weight, mortality, faecal egg counts and immunological markers.
Andre Prassinos, Managing Director of BioBrew Ltd, said he hoped the study would prove as successful as a previous trial of calves in the Clutha District in 2013, which demonstrated a positive effect on animal growth rates in calves treated with a BioBrew probiotic supplement.